Ichosia Biotechnology

George Washington University

Ichosia is developing a scalable method of producing an enhanced red blood cell product, called Erythrosyn, created by leveraging proprietary genetic engineering and stem cell technologies to address the global blood crisis with a safer, less expensive, and more reliable product.